Physical exercise for obesity and T2DM mitigation in polycystic ovary syndrome: the role of adipose tissue

Abstract

Polycystic ovary syndrome (PCOS) is a complex disorder with a great heterogeneity of signs and symptoms. However, hyperandrogenism is considered a hallmark of PCOS, presented by most affected women. Women with PCOS are at high risk of developing type 2 diabetes mellitus (T2DM), which is associated with insulin resistance (IR) and hyperinsulinemia. In turn, hyperinsulinemia interferes with the androgen production by ovarian cells, and worsens the hyperandrogenism, initiating a feedback cycle. Women with PCOS are also at a greater risk of developing obesity. Indeed, a dysfunctional adipose tissue in obesity contributes to T2DM in PCOS by affecting insulin action and secretion through multiple mechanisms, such as lipotoxicity, inflammation, and adipokine signaling. Therefore, obesity-disrupted adipose tissue can be seen as an important target for T2DM development in women with PCOS. Because adipose tissue can be positively affected by non-pharmacological and easily accessible strategies such as physical exercise, this review provides a comprehensive summary of the benefits of physical exercise to improve adipose tissue health and decrease the risk of obesity and T2DM in women with PCOS.

Keywords

Polycystic ovary syndrome / type 2 diabetes mellitus / obesity / adipose tissue / physical exercise

References

[1] Teede HJ,Laven JJE.Recommendations from the 2023 International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome.J Clin Endocrinol Metab2023;108:2447-69 PMCID:PMC10505534

[2] Azziz R.Polycystic ovary syndrome.Obstet Gynecol2018;132:321-36

[3] ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod2004;19:41-7

[4] Sivanandy MS.The role of serum anti-mullerian hormone measurement in the diagnosis of polycystic ovary syndrome.Diagnostics2023;13:907 PMCID:PMC10000702

[5] Stener-Victorin E,Walters KA.Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome.Endocr Rev2020;41:bnaa010 PMCID:PMC7279705

[6] Hart R,Franks S.Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.Best Pract Res Clin Obstet Gynaecol2004;18:671-83

[7] Deeks AA,Teede HJ.Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation.Fertil Steril2010;93:2421-3

[8] Dunaif A,Futterweit W.Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.Diabetes1989;38:1165-74

[9] Carmina E.Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.Fertil Steril2004;82:661-5

[10] Lemaitre M,Kerlan V.Polycystic ovary syndrome and adipose tissue.Ann Endocrinol2023;84:308-15

[11] Spritzer PM,Satler F.Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.Reproduction2015;149:R219-27

[12] Kahn SE,Utzschneider KM.Mechanisms linking obesity to insulin resistance and type 2 diabetes.Nature2006;444:840-6

[13] Kakoly NS,Teede HJ,Joham AE.The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome.Diabetes Care2019;42:560-7

[14] Chantrapanichkul P,Wongwananuruk T,Dangrat C.Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.Arch Gynecol Obstet2020;301:809-16

[15] Samaras K,De Glizesinski J.Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.Obesity2010;18:884-9

[16] De Glisezinski I,Bajzova M.Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.J Physiol2009;587:3393-404 PMCID:PMC2727046

[17] Shoupe D,Lobo RA.Insulin resistance in polycystic ovary syndrome.Am J Obstet Gynecol1983;147:588-92

[18] Chang RJ,Judd HL.Insulin resistance in nonobese patients with polycystic ovarian disease.J Clin Endocrinol Metab1983;57:356-9

[19] Baillargeon JP.Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity.Fertil Steril2007;88:886-93 PMCID:PMC3846535

[20] Dumesic DA.Implications of polycystic ovary syndrome on oocyte development.Semin Reprod Med2008;26:53-61 PMCID:PMC2655636

[21] Hong SH,Hong YS,Chung H.Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.Clin Endocrinol2017;87:375-80

[22] Diamanti-Kandarakis E,Boutzios G.Pancreatic beta-cells dysfunction in polycystic ovary syndrome.Panminerva Med2008;50:315-25

[23] Dunaif A.Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.J Clin Endocrinol Metab1996;81:942-7

[24] Mishra JS,Kumar S.Elevated androgen levels induce hyperinsulinemia through increase in Ins1 transcription in pancreatic beta cells in female rats.Biol Reprod2018;98:520-31 PMCID:PMC6279097

[25] Wang H,Zhu Y,Sun Y.Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function.J Steroid Biochem Mol Biol2015;154:254-66

[26] Malin SK,Sia CL.Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.J Clin Endocrinol Metab2014;99:322-9 PMCID:PMC3879676

[27] Rae M,Hogg K.The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS).PLoS One2013;8:e56263 PMCID:PMC3574134

[28] Vine D,Wang T.Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a canadian population cohort.CJC Open2024;6:314-26 PMCID:PMC10935704

[29] Liao WT,Lee MT,Wu CC.Higher risk of type 2 diabetes in young women with polycystic ovary syndrome: a 10-year retrospective cohort study.World J Diabetes2022;13:240-50 PMCID:PMC8984565

[30] Azziz R.Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling.J Clin Endocrinol Metab2002;87:4085-7

[31] World Health Organization. Diabetes. Available from https://www.who.int/health-topics/diabetes [accessed 7 March 2025]

[32] Chawla A,Jaggi S.Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?.Indian J Endocrinol Metab2016;20:546-51 PMCID:PMC4911847

[33] International Diabetes Federation. IDF Diabetes Atlas 2021. Available from https://diabetesatlas.org/atlas/tenth-edition/ [accessed 7 March 2025]

[34] Tinajero MG.An update on the epidemiology of type 2 diabetes: a global perspective.Endocrinol Metab Clin North Am2021;50:337-55

[35] Bellou V,Tzoulaki I.Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses.PLoS One2018;13:e0194127 PMCID:PMC5860745

[36] Ryu KJ,Kim HK.Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.Fertil Steril2021;115:1569-75

[37] Livadas S,Anagnostis P.Assessment of type 2 diabetes risk in young women with polycystic ovary syndrome.Diagnostics2023;13:2067 PMCID:PMC10297688

[38] Holte J,Wide L,Berne C.High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.J Clin Endocrinol Metab1998;83:1143-50

[39] Kousta E,Lawrence N.The prevalence of polycystic ovaries in women with a history of gestational diabetes.Clin Endocrinol2000;53:501-7

[40] Conn JJ,Conway GS.The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.Clin Endocrinol2000;52:81-6

[41] Long C,Duan W.Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: a systematic review and meta-analysis.Front Endocrinol2022;13:980405 PMCID:PMC9471325

[42] Baillargeon JP.Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?.J Clin Endocrinol Metab2006;91:22-4 PMCID:PMC3846532

[43] Risal S,Lu H.Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome.Nat Med2019;25:1894-904

[44] Zhang J,Zhang L.Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.Eur Rev Med Pharmacol Sci2023;27:3255-69

[45] Shaaban Z,Amiri-Yekta A,Jafarzadeh Shirazi MR.Pathophysiologic mechanisms of insulin secretion and signaling-related genes in etiology of polycystic ovary syndrome.Genet Res2021;2021:7781823 PMCID:PMC8668318

[46] Abbott DH,Franks S.Developmental origin of polycystic ovary syndrome - a hypothesis.J Endocrinol2002;174:1-5

[47] Tata B,Barbotin AL.Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.Nat Med2018;24:834-46 PMCID:PMC6098696

[48] Shen HR,Zhang ZQ,Cao C.Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome.PLoS One2013;8:e64801 PMCID:PMC3660316

[49] Makrinou E,Christopoulos G.Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS).Mol Cell Endocrinol2020;500:110611 PMCID:PMC7116598

[50] Mimouni NEH,Barbotin AL.Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process.Cell Metab2021;33:513-30.e8 PMCID:PMC7928942

[51] Parker J.Pathophysiological effects of contemporary lifestyle on evolutionary-conserved survival mechanisms in polycystic ovary syndrome.Life2023;13:1056 PMCID:PMC10145572

[52] Bruni V,Lello S.The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art.Reprod Sci2022;29:668-79

[53] Ali O.Genetics of type 2 diabetes.World J Diabetes2013;4:114-23 PMCID:PMC3746083

[54] Azarova I,Klyosova E.Molecular genetics of abnormal redox homeostasis in type 2 diabetes mellitus.Int J Mol Sci2023;24:4738 PMCID:PMC10418503

[55] Grant SF,Reynisdottir I.Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.Nat Genet2006;38:320-3

[56] Zhou Y,Su J.TCF7L2 is a master regulator of insulin production and processing.Hum Mol Genet2014;23:6419-31 PMCID:PMC4240194

[57] Ding W,Zhang L.Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus.BMC Med Genet2018;19:38 PMCID:PMC5842570

[58] Sakers A,Seale P.Adipose-tissue plasticity in health and disease.Cell2022;185:419-46 PMCID:PMC11152570

[59] Azevedo-Martins AK,Abayomi J,Evangelista FS.The impact of excessive fructose intake on adipose tissue and the development of childhood obesity.Nutrients2024;16:939 PMCID:PMC11013923

[60] Scheja L.The endocrine function of adipose tissues in health and cardiometabolic disease.Nat Rev Endocrinol2019;15:507-24

[61] Basolo A,Piaggi P,Santini F.Energy balance and control of body weight: possible effects of meal timing and circadian rhythm dysregulation.Nutrients2021;13:1-13 PMCID:PMC8470941

[62] Horwitz A.Adipose tissue hyperplasia and hypertrophy in common and syndromic obesity-the case of BBS obesity.Nutrients2023;15:3445 PMCID:PMC10421039

[63] Li Q.The regulation of adipocyte growth in white adipose tissue.Front Cell Dev Biol2022;10:1003219 PMCID:PMC9723158

[64] Loos RJF.The genetics of obesity: from discovery to biology.Nat Rev Genet2022;23:120-33 PMCID:PMC8459824

[65] Kurokawa N,Oka Y.The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals.Int J Obes2008;32:1240-9

[66] Wang D,Zhang S.Association of the MC4R V103I polymorphism with obesity: a Chinese case-control study and meta-analysis in 55,195 individuals.Obesity2010;18:573-9

[67] Ponce-Gonzalez JG,Velázquez-Díaz D.Impact of the FTO gene variation on appetite and fat oxidation in young adults.Nutrients2023;15:2037 PMCID:PMC10181223

[68] Sun K,Scherer PE.Adipose tissue remodeling and obesity.J Clin Invest2011;121:2094-101 PMCID:PMC3104761

[69] Targher G,Byrne CD.The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.Nat Rev Gastroenterol Hepatol2021;18:599-612

[70] Oh YS,Baek DJ,Jun HS.Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes.Front Endocrinol2018;9:384 PMCID:PMC6054968

[71] Azevedo-Martins AK,Lima CL,Curi R.Fatty acid-induced toxicity and neutral lipid accumulation in insulin-producing RINm5F cells.Toxicol In Vitro2006;20:1106-13

[72] Shi J,Su Q.Cytokines and abnormal glucose and lipid metabolism.Front Endocrinol2019;10:703 PMCID:PMC6833922

[73] Zorena K,Ślęzak D,Mrugacz M.Adipokines and obesity. Potential link to metabolic disorders and chronic complications.Int J Mol Sci2020;21:3570 PMCID:PMC7278967

[74] Marroquí L,Nẽco P.Role of leptin in the pancreatic β-cell: effects and signaling pathways.J Mol Endocrinol2012;49:R9-17

[75] Nieto-Vazquez I,Krämer DK,Garcia-Guerra L.Insulin resistance associated to obesity: the link TNF-alpha.Arch Physiol Biochem2008;114:183-94

[76] Stephens LA,Ming L.Tumor necrosis factor-α-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic β cells.Endocrinology1999;140:3219-27

[77] Ammendrup A,Nielsen K.The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells.Diabetes2000;49:1468-76

[78] Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024.Diabetes Care2024;47:S20-42 PMCID:PMC10725812

[79] Echiburú B,Galgani JE.Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome.Steroids2018;130:15-21

[80] Chen L,Zhang D.Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.Fertil Steril2014;102:1167-74.e4

[81] Xiong T,Edwards MC.Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.Am J Physiol Endocrinol Metab2022;323:E145-58

[82] Scarfò G,Fusi J.Metabolic and molecular mechanisms of diet and physical exercise in the management of polycystic ovarian syndrome.Biomedicines2022;10:1305 PMCID:PMC9219791

[83] Panidis D,Papadakis E,Chatzis P.Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.Endocrine2013;44:583-90

[84] Almenning I,Lundgren KM,Garnæs KK.Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study.PLoS One2015;10:e0138793 PMCID:PMC4583183

[85] Leidy HJ,Astrup A.The role of protein in weight loss and maintenance.Am J Clin Nutr2015;101:1320S-9S

[86] Kogure GS,Silva RC.Resistance exercise impacts lean muscle mass in women with polycystic ovary syndrome.Med Sci Sports Exerc2016;48:589-98

[87] Kite C,Afzal I.Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis.Syst Rev2019;8:51 PMCID:PMC6438659

[88] Ribeiro VB,Lopes IP.Effects of continuous and intermittent aerobic physical training on hormonal and metabolic profile, and body composition in women with polycystic ovary syndrome: a randomized controlled trial.Clin Endocrinol2020;93:173-86

[89] Patten RK,Moholdt T.Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis.Front Physiol2020;11:606 PMCID:PMC7358428

[90] Breyley-Smith A,Teede HJ,Sabag A.The effect of exercise on cardiometabolic risk factors in women with polycystic ovary syndrome: a systematic review and meta-analysis.Int J Environ Res Public Health2022;19:1386 PMCID:PMC8835550

[91] Mohammadi S,Alavimilani S.Effects of eight-week high-intensity interval training on some metabolic, hormonal and cardiovascular indices in women with PCOS: a randomized controlled trail.BMC Sports Sci Med Rehabil2023;15:47 PMCID:PMC10124995

[92] Ruiz-González D,Hernández-Martínez A.Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis.Hum Reprod Update2024;30:472-87 PMCID:PMC11215161

[93] Gómez-Ambrosi J,Galofré JC.Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI.Obesity2011;19:1439-44

[94] Orio F,Giallauria F.Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.Clin Endocrinol2016;85:764-71

[95] Aktaş HŞ,Kutlu O.The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome.Arch Physiol Biochem2022;128:37-42

[96] Vizza L,Swaraj S,Cheema BS.The feasibility of progressive resistance training in women with polycystic ovary syndrome: a pilot randomized controlled trial.BMC Sports Sci Med Rehabil2016;8:14 PMCID:PMC4865007

[97] Miranda-Furtado CL,Kogure GS.A nonrandomized trial of progressive resistance training intervention in women with polycystic ovary syndrome and its implications in telomere content.Reprod Sci2016;23:644-54

[98] Saremi A.Effect of resistance exercises with calcium consumption on level of anti-mullerian hormone and some metabolic indices in women with polycystic ovarian syndrome.Iran J Obstet Gynecol Infertil2016;18:7-15

[99] Kite C,Taylor SR.Time to load up-resistance training can improve the health of women with polycystic ovary syndrome (PCOS): a scoping review.Med Sci2022;10:53 PMCID:PMC9590069

[100] Chou TJ,Lu CW,Huang CC.Effects of aerobic, resistance, and high-intensity interval training on thermogenic gene expression in white adipose tissue in high fat diet induced obese mice.Obes Res Clin Pract2024;18:64-72

[101] Ruze R,Zou X.Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments.Front Endocrinol2023;14:1161521 PMCID:PMC10161731

[102] Moro C,Elkind-Hirsch K.Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.J Clin Endocrinol Metab2009;94:2579-86 PMCID:PMC5393377

[103] Lima-Silva AE, Adami F, Nakamura FY, de Oliveira FR, Gevaerd MS. Metabolismo de gordura durante o exercício físico: mecanismos de regulação. Rev Bras Cineantropometria Desempenho Hum. 2006;4:106-114. (in Portuguese)

[104] Ljubicic V,Saleem A.Transcriptional and post-transcriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging.Biochim Biophys Acta2010;1800:223-34

[105] Vecchiatto B,Higa TS.Oxidative phenotype induced by aerobic physical training prevents the obesity-linked insulin resistance without changes in gastrocnemius muscle ACE2-Angiotensin(1-7)-Mas axis.Diabetol Metab Syndr2021;13:74 PMCID:PMC8262010

[106] Ormsbee MJ,Medlin JK.Regulation of fat metabolism during resistance exercise in sedentary lean and obese men.J Appl Physiol2009;106:1529-37

[107] Washburn RA,Smith BK.One set resistance training: effect on body composition in overweight young adults.J Sports Med Phys Fitness2012;52:273-9

[108] Polak J,Stich V.Effect of exercise on lipolysis in adipose tissue.Future Lipidology2008;3:557-72

[109] Higa TS,Fonseca-Alaniz MH.Remodeling of white adipose tissue metabolism by physical training prevents insulin resistance.Life Sci2014;103:41-8

[110] Américo ALV,Vecchiatto B,Fonseca-Alaniz MH.Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue.PLoS One2019;14:e0215896 PMCID:PMC6483229

[111] Anthony SR,Gozdiff A,Phillip Owens A.Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.Clin Sci2019;133:2329-44 PMCID:PMC7191542

[112] Chondronikola M,Børsheim E.Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.Diabetes2014;63:4089-99 PMCID:PMC4238005

[113] Bartelt A,Reimer R.Brown adipose tissue activity controls triglyceride clearance.Nat Med2011;17:200-5

[114] Stanford KI,Townsend KL.Brown adipose tissue regulates glucose homeostasis and insulin sensitivity.J Clin Invest2013;123:215-23 PMCID:PMC3533266

[115] Vidal P.Exercise-induced adaptations to adipose tissue thermogenesis.Front Endocrinol2020;11:270 PMCID:PMC7201000

[116] Wang N,Ma Y.High-intensity interval versus moderate-intensity continuous training: superior metabolic benefits in diet-induced obesity mice.Life Sci2017;191:122-31

[117] Motiani KK,Eskelinen JJ.Two weeks of moderate-intensity continuous training, but not high-intensity interval training, increases insulin-stimulated intestinal glucose uptake.J Appl Physiol2017;122:1188-97 PMCID:PMC5451533

[118] Martinez-Tellez B,Acosta FM.No evidence of brown adipose tissue activation after 24 weeks of supervised exercise training in young sedentary adults in the ACTIBATE randomized controlled trial.Nat Commun2022;13:5259 PMCID:PMC9467993

[119] Lehnig AC.Exercise-induced adaptations to white and brown adipose tissue.J Exp Biol2018;221:jeb161570 PMCID:PMC6524684

[120] Wu J,Spiegelman BM.Adaptive thermogenesis in adipocytes: is beige the new brown?.Genes Dev2013;27:234-50 PMCID:PMC3576510

[121] Otero-Díaz B,Sánchez-Muñoz V.Exercise induces white adipose tissue browning across the weight spectrum in humans.Front Physiol2018;9:1781 PMCID:PMC6297830

[122] Kim HJ,So B,Yoon D.Effect of aerobic training and resistance training on circulating irisin level and their association with change of body composition in overweight/obese adults: a pilot study.Physiol Res2016;65:271-9

[123] Perakakis N,Fernández-Real JM.Physiology and role of irisin in glucose homeostasis.Nat Rev Endocrinol2017;13:324-37 PMCID:PMC5878942

[124] Kim H,Jedrychowski M.Irisin mediates effects on bone and fat via αv integrin receptors.Cell2018;175:1756-68.e17 PMCID:PMC6298040

[125] Egan B.Exercise metabolism and the molecular regulation of skeletal muscle adaptation.Cell Metab2013;17:162-84

[126] Drake JC,Yan Z.Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle.FASEB J2016;30:13-22 PMCID:PMC6137621

[127] Choe SS,Hwang IJ,Kim JB.Adipose tissue remodeling: its role in energy metabolism and metabolic disorders.Front Endocrinol2016;7:30 PMCID:PMC4829583

[128] Ring-Dimitriou S,von Duvillard SP.The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome.Eur J Appl Physiol2006;98:472-81

[129] Lim S,Jeong IK.Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women.J Clin Endocrinol Metab2008;93:2263-8

[130] Hulver MW,Tanner CJ.Adiponectin is not altered with exercise training despite enhanced insulin action.Am J Physiol Endocrinol Metab2002;283:E861-5

[131] Jürimäe J,Jürimäe T.Effect of prolonged training period on plasma adiponectin in elite male rowers.Horm Metab Res2007;39:519-23

[132] Recchia F,Yu AP.Dose-response effects of exercise and caloric restriction on visceral adiposity in overweight and obese adults: a systematic review and meta-analysis of randomised controlled trials.Br J Sports Med2023;57:1035-41 PMCID:PMC10423480

[133] Lee S,Dellsperger KC.Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice.Am J Physiol Heart Circ Physiol2011;301:H306-14 PMCID:PMC3154670

[134] Becic T,Hoffmann G.Exercise increases adiponectin and reduces leptin levels in prediabetic and diabetic individuals: systematic review and meta-analysis of randomized controlled trials.Med Sci2018;6:97 PMCID:PMC6318757

[135] Kanaley JA,Miller CS.Resting leptin responses to acute and chronic resistance training in type 2 diabetic men and women.Int J Obes Relat Metab Disord2001;25:1474-80

[136] Rosen ED.Adipocytes as regulators of energy balance and glucose homeostasis.Nature2006;444:847-53 PMCID:PMC3212857

[137] Ozcelik O,Ayar A,Kelestimur H.Investigation of the influence of training status on the relationship between the acute exercise and serum leptin levels in obese females.Neuro Endocrinol Lett2004;25:381-5

[138] Polak J,Moro C.Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women.Metabolism2006;55:1375-81

[139] Covington JD,Pasarica M.Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise.Biochimie2016;124:27-33 PMCID:PMC4429000

[140] Zafeiridis A,Considine RV.Serum leptin responses after acute resistance exercise protocols.J Appl Physiol2003;94:591-7

[141] Racil G,Elmontassar W.Plyometric exercise combined with high-intensity interval training improves metabolic abnormalities in young obese females more so than interval training alone.Appl Physiol Nutr Metab2016;41:103-9

[142] Thompson D,Lafontan M.Physical activity and exercise in the regulation of human adipose tissue physiology.Physiol Rev2012;92:157-91

[143] Silvestris E,Rosania R.Obesity as disruptor of the female fertility.Reprod Biol Endocrinol2018;16:22 PMCID:PMC5845358

[144] Dantas WS,Gil S.Exercise-induced anti-inflammatory effects in overweight/obese women with polycystic ovary syndrome.Cytokine2019;120:66-70

[145] Moori M, Nosratabadi S, Yazdi N, Kasraei R, Abbasi Senjedary Z, Hatami R. The effect of exercise on inflammatory markers in PCOS women: a systematic review and meta-analysis of randomized trials.Int J Clin Pract2023;2023:3924018 PMCID:PMC9934983